Last price paid | 0.39 | |
Change | -13.33% [ -0.06 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 15.08.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | -24.51% |
Year to date (YTD) | -61.76% |
1 month | -53.01% |
3 months | -22.00% |
1 year | -35.00% |
3 years | n.a. |
Issue price | 0.51 |
Underlying price on issue | 164.35 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250734311 |
Symbol | IMRLUZ |
Security | 125073431 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Merck I, DE0006599905 |
Underlying ISIN | DE0006599905 |
Funding level | 184.301300 |
Stop-loss level | 176.949700 |
Distance to stop-loss level | 4.24% |
Long/Short type | Short |
Subscription ratio | 40.00 |
Issuer | Zuercher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 0.91% |
Premium p.a. | n.a. |
Leverage | 10.55 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 14.551300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
UBS | 26.40 |
NOVARTIS N | 99.27 |
Sika AG | 257.70 |
Givaudan | 4'186.00 |
KUEHNE & NAGEL | 259.00 |
Name | Price |
---|---|
GEBERIT N | 512.40 |
Alcon AG | 81.96 |
Partners Group Ho... | 1'185.00 |
ABB Ltd | 47.24 |
Compagnie Financi... | 133.10 |